Surveillance of menstrual patterns and adverse effect for LH-RH agonist therapy in premenopausal hormone receptor-positive breast cancer patients

Surveillance of menstrual patterns and adverse effect for LH-RH agonist therapy in premenopausal hormone receptor-positive breast cancer patients - Surveillance of menstrual patterns and adverse effect for LH-RH agonist therapy in premenopausal hormone receptor-positive breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023112

Enrollment

100

Registered

2016-07-12

Start date

2016-07-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. premenopausal women 2. Breast cancer patients with hormone receptor-positive 3. Patients scheduled to administer the LH-RH agonist 4. Preoperative or postoperative hormone receptor-positive patient , hormone receptor-positive patients with no prior treatment as metastatic or recurrent treatment

Exclusion criteria

Exclusion criteria: 1. Patients undergoing total hysterectomy surgery of the uterus 2. Patients registration to this study is deemed difficult due to mental disorders clinically relevant

Design outcomes

Primary

Measure	Time frame
side effect of the incidence of post-dose after 3 months and QOL	—

Countries

Japan

Contacts

Public ContactYasunori Miyamoto

Hamamatsu Medical Center Division of Pharmacy

ymiyamo@hmedc.or.jp053-453-7111

Outcome results